Annotation Detail

Information
Associated Genes
NRAS
Associated Variants
NRAS G13D
Source Database
MMMP
Description
17-AAG: HSP90 inhibitor. The only patient who had a NRAS mutation (together with wild type BRAF) had a prolonged time to progression of 49 months, which is in excess of what is clinically predicted for metastatic melanoma
MMMP State
mut G13D
MMMP Molecule
NRAS
MMMP Molecule Alias
N-Ras
MMMP Relationship
sensitivity to
MMMP Drug
17-AAG
MMMP Drug Alias
Tanespimycin (17-allylamino-17-demethoxygeldanamycin)
MMMP Model
5
MMMP Reference
Banerji U, Mol Cancer Ther 2008, 7:737-9
MMMP DNA/mRNA/Protein
DNA
Drugs
Drug NameSensitivitySupported
17-AAGSensitivitytrue